ASRM Responds to Supreme Court Ruling on Mifepristone
For Immediate Release
Washington, DC – “We are thrilled that a unanimous Supreme Court has rejected the ideologically driven lower court decisions on access to mifepristone, reversing an action that has already endangered too many people in need of healthcare. The decision further affirms the robust drug safety program at the United States FDA.
We are pleased that Americans will retain access to this essential medication, and that physicians will be able to provide evidence-based care for their patients. We hope that this marks a turning point in how our nation’s decision-makers evaluate access to reproductive healthcare.”
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Fertility in the News
ASRM Hosts Briefing on New Fertility Benefits for Members of Congress and Congressional Staff
ASRM hosts a Capitol Hill briefing to raise awareness of new fertility benefits for Congress members and staff, highlighting expanded coverage for IVF and fertility treatments.
ASRM Applauds Passage of Reproductive Rights Ballot Measures in 7 States
ASRM applauds reproductive rights measures passed in 7 states, protecting access to reproductive care. Support remains strong nationwide, as ASRM advocates forward.
Resources For You
Find a Health Professional
Reproductive Rights
ASRM Applauds Passage of Reproductive Rights Ballot Measures in 7 States
ASRM applauds reproductive rights measures passed in 7 states, protecting access to reproductive care. Support remains strong nationwide, as ASRM advocates forward.
View the Press Release
ASRM Releases Congressional Scorecard
Discover ASRM's first Congressional scorecard, detailing positions of the 118th Congress on key reproductive legislation to guide ASRM members in elections.
View the Press Release
ASRM Launches National Campaign in Support of Reproductive Rights Ballot Measures
ASRM launches a national campaign supporting reproductive rights ballot measures in 10 states with ads, endorsements, and voter engagement efforts.
View the Press Release
ASRM Responds to Supreme Court Ruling on Mifepristone
We are thrilled that a unanimous Supreme Court has rejected the ideologically driven lower court decisions on access to mifepristone.
View the Press Release
Take Action Now!
Like you, ASRM is extremely concerned over the decision from the Supreme Court to overturn Roe v. Wade and its impact. Learn How Your Can Help
Advocacy Toolkit
It takes more than one
Why IVF patients often need multiple embryos to have a baby View the advocacy resource
What support for IVF looks like
Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow. View the advocacy resource
